← Leaderboards
Chris H Takimoto
University Of Texas Hlth Sci Ctr San Ant
$721,754
Attributed
$721,754
Total exposure
7
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $15.3K · FY2005–06$20K$15K$10K$5K$0
'05
'06
Funding mix
By agency
NIH$721,754 · 7
By mechanism
K12$424,669 · 1
R21$264,086 · 1
M01$32,999 · 5
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Hlth Sci Ctr San Ant
Same institution · by research overlap
- Steven Schenker$1,507,476
- Eric K Rowinsky$9,623,858
- Lisa Hammond$720,920
- Steven M. Haffner$17,928,238
- Michael L Parchman$17,128,029
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationClinical ResearchDrug Screening /EvaluationClinical Trial Phase INeoplasm /Cancer ChemotherapyHuman SubjectMetastasisBlood ChemistryUrinalysisDosageChronic Myelogenous LeukemiaDrug Adverse EffectPharmacokineticsKinase InhibitorPyrimidine AnalogKidney DisorderKidney FunctionKidney NeoplasmsLiver DisorderLiver Disorder ChemotherapyLiver NeoplasmsMedical EducationNeoplasm /Cancer Blood SupplyNeoplasm /Cancer Pharmacology
Grant awards (7)
PH I STUDY OF BMS-247550 GIVEN ON CONTINUOUS WEEKLY SCHEDULE IN PTS W/ADV MALIG$3,568
M01 · FY2006 · RR · contact PI
PH I STUDY OF BMS-247550 GIVEN ON CONTINUOUS WEEKLY SCHEDULE IN PTS W/ADV MALIG$10,543
M01 · FY2005 · RR
PH I PK STUDY OF PS341 IN PTS WITH ADVANCED MALIGNANCIES AND RENAL DYSFUNCTION$4,792
M01 · FY2005 · RR
Ph I Pharmacokinetics of STI571 in Cancer &Liver Dis$10,482
M01 · FY2004 · RR
Ph I Pharmacokinetics of STI571 in Neoplasms/kidney Dis$3,614
M01 · FY2004 · RR
ERBB1 AND ERBB2 BLOCKADE IN ADVANCED BREAST CANCER$264,086
R21 · FY2003 · CA
PHYSICIAN SCIENTIST TRAINING GRANT IN ONCOLOGY$424,669
K12 · FY2001 · CA